Enteral Feeding Devices Market
The global enteral feeding devices market worth $5.2 billion by 2030, growing at a CAGR of 6.9% in the upcoming years.
The movement of patients from parenteral to enteral nutrition is driving the growth of this market. Enteral nutrition has fewer complications than parenteral feeding. Furthermore, developments in enteral feeding technology such as enteral feeding pumps and enteral feeding tubes are favouring enteral feeding therapies over parenteral feeding therapies.
Enteral Feeding Devices Market Dynamics
Drivers: Premature births and genetic abnormalities are common in paediatric and neonatal patients.
Because of the related newborn mortality and short- or long-term illness, preterm births have become a serious public health problem worldwide. Pre-term newborns weighing less than 1,500 grammes require adequate nutrition to promote normal development. Pre-term newborns' inability to synchronise swallowing, sucking, and breathing needs bolus feeding and human milk administration via enteral nutrition techniques. Furthermore, infants born with genetic problems, such as congenital genetic disorders and uncommon genetic diseases like Prader-Willi Syndrome, require tube feeding. As a consequence, rising demand for enteral feeding therapy in neonates and babies is propelling the enteral feeding devices market's revenue growth.
Restraints: Complications caused with enteral feeding devices
Some of the key issues connected with the use of an enteral feeding system are initial installation complications, mechanical complications, clinical problems, and nutritional problems, all of which result in higher healthcare expenditures. The majority of enteral feeding issues are mild, but some can be fairly significant. Despite their reduced frequency and severity, enteral feeding metabolic problems are substantially comparable to those seen with parenteral nutrition. Careful monitoring can help lessen or eliminate these issues. These concerns, together with the mortality associated with these issues, operate as a deterrent to the use of enteral feeding systems.
Opportunities: Significant growth potential exist for industry participants in emerging countries.
Emerging economies in the Asia Pacific area are projected to provide market participants with significant growth possibilities in the future years. This is largely due to increased R&D activities to produce breakthrough medical technology, diverse healthcare markets in this area, and an increase in the prevalence of infectious and chronic diseases. Cancer, for example, is one of the most common illnesses in emerging nations such as India, China, and Brazil. Furthermore, Asia has the highest rate of premature births among growing economies. Improvements in healthcare systems across Asia, along with increasing patient knowledge of treatment alternatives, have increased the usage of sophisticated nutritional therapy, pushing the acceptance of enteral feeding devices across emerging markets.
Challenges: In underdeveloped nations, there are insufficient reimbursement policies for enteral nutrition treatment.
Enteral nutrition is commonly defined by third-party payers as tube feeding for individuals who are unable to swallow meals orally. Enteral nutrition treatment is funded in industrialised nations such as the United States, Germany, France, Canada, Japan, and the United Kingdom. Enteral feeding reimbursements, on the other hand, are insufficient in poor countries throughout Latin America, Asia Pacific, and the Middle East. Inadequate payment rules impede the broad use of enteral feeding in poor nations. The challenges confronting competitors in the enteral feeding devices market are expected to increase over the next five years as a result of decreasing government funding and related reimbursement reductions for home healthcare services.
In 2021, enterostomy feeding tubes will dominate the enteral feeding devices market by type.
Enterostomy tubes are enteral feeding tubes that are inserted directly through the abdominal wall into the stomach/duodenum/jejunum via endoscopy, laparoscopy, or open surgery. These tubes are frequently used for long-term enteral assistance (lasting more than four weeks). Technological advancements such as the introduction of reverse balloon designs and the creation of tri-funnel replacement enterostomy tubes are expected to fuel the market for enterostomy feeding tubes.
In the enteral feeding devices market in 2021, adult patients will lead the age group sector.
Adults are more vulnerable to chronic illnesses and disorders than children, including cancer, multiple sclerosis, liver disease, motor neuron disease, Parkinson's disease, sepsis, anorexia, cystic fibrosis, dementia, and inflammatory bowel disease. The growing senior population and the increasing prevalence of chronic illnesses have raised the demand for comprehensive nutrition management to help people maintain their weight, recover faster, and respond better to therapy. Tube feeding is advised for these patients because it aids in the maintenance of small intestinal bulk and pancreatic functioning, improves the overall healing and recovery process, and minimises muscle catabolism. As a result, the adult age group leads the worldwide market.
The enteral feeding devices market's head and neck cancer subsegment will expand the quickest by type of oncology application.
Cancers of the oral and nasal cavities, sinuses, salivary glands, pharynx, larynx, and lymph nodes in the neck are all examples of head and neck cancers. Maintaining optimal nutrition for head and neck cancer patients is critical since patients frequently struggle with eating well throughout treatment. The majority of patients with head and neck cancer have normal GI function but significant oral intake issues. As a result, the enteral route is employed to provide nutritional assistance. The rising prevalence of head and neck cancer is boosting demand for enteral feeding devices in this market.
The Asia Pacific region will have the greatest growth rate in the enteral feeding devices market during the projected period.
Asia Pacific is the fastest-growing market for enteral feeding systems, with demand expanding rapidly in developing Asia Pacific nations such as China, India, South Korea, Malaysia, and Vietnam. This growth in demand might be ascribed to lifestyle and eating habits changes, which are increasing the incidence of obesity and other chronic disorders. Governments in this region are working to improve healthcare conditions by funding cancer awareness projects, free health check-ups, and patient education programmes, as well as providing cash for the research of novel treatment alternatives. Such initiatives have broadened access to innovative healthcare solutions, boosting demand for a variety of medical gadgets, including enteral feeding items.Furthermore, key market players are boosting their investments in the Asia Pacific area in order to capitalise on the high-growth potential of rising countries such as China and India.
Shift of healthcare provision from hospital to community settings
Many healthcare systems (mostly in affluent nations such as the United States and some European countries) are shifting specialised services from acute hospitals to the community in order to offer care closer to patients' homes. Diabetes, cancer, and other long-term gastrointestinal diseases necessitate a well-balanced nutritional intake delivered by tube feeds when not taken orally. Patients with such diseases or on cancer-prevention therapy regimens find that using enteral feeding systems at home is more convenient and cost-effective. With the increasing prevalence of various disorders, the usage of these devices in home care settings has increased. Companies in the global market are always concentrating on offering new and better products in order to get a larger market share. Current market developments attempt to improve the quality of human life by improving the process of acquiring vital nutrients.
The enteral feeding devices market is dominated by globally established players such as Nestlé S.A. (Switzerland), Fresenius Kabi AG (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), and B. Braun Melsungen AG (Germany).
Enteral Feeding Devices Market Report Scope:
The study categorizes the enteral feeding devices market into following segments & sub-segments:
By Product Type
- Enteral Feeding Tubes
- Enterostomy Feeding Tubes
- Standard Tubes
- Standard Gastrostomy Tubes
- Standard Jejunostomy Tubes
- Standard Gastrojejunostomy Tubes
- Low-profile Tubes
- Low-profile Gastrostomy Tubes
- Low-profile Jejunostomy Tubes
- Low-profile Gastrojejunostomy Tubes
- Standard Tubes
- Nasoenteric Feeding Tubes
- Nasogastric Feeding Tubes
- Nasojejunal Feeding Tubes
- Nasoduodenal Feeding Tubes
- Oroenteric Feeding Tubes
- Enteral Feeding Pumps
- Administration Sets
- Enteral Syringes
- Consumables
By Age Group
- Adults
- Pediatric
By End User
- Hospitals
- Home Care Settings
- Ambulatory Care Settings
By Application
- Oncology
- Head &Nech Cancer
- Stomach & Gastrointestinal Cancer
- Liver Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Other Cancer
- Gastrointestinal Diseases
- Neurological Disorders
- Diabetes
- Hypermetabolism
- Other Applications
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In November 2022, Medela AG (US) will establish a collaboration with Ronald McDonald House Charities (US). As part of the company's compassionate commitment to combat child mortality and malnutrition, Medela formed a partnership with the non-profit Ronald McDonald House Charities in the United States to help its 60 programmes around the world by donating NICU equipment through its breastfeeding business unit.
- Amsino Medical Group Company announced in November 2022 that its AMSafeNeuFlo Needleless Connector has achieved US FDA 510(k) approval.
- In March 2022, Vygon (France) announced the acquisition of distributor MacattMedica (Peru). The acquisition is meant to boost Vygon's (France) position in the South American market, notably for its comprehensive line of enteral feeding products.
- In March 2021, Applied Medical Technology, Inc. (US) extended its gastric-jejunal enteral feeding tube (G-JET) line to include the low-profile micro-G-JET to meet the enteral nutrition needs of paediatric patients.